Muhammad Aasim Ali: Treatment Strategies for Chemotherapy-Induced Cytopenias
Muhammad Aasim Ali, Pharmacist at Premium Care Medical Polyclinic, shared a post on LinkedIn:
”Cancer Myelosuppression Treatment
Cancer therapy–induced myelosuppression:
Neutropenia:
Granulocyte colony-stimulating factors include:
- filgrastim
- pegfilgrastim
They act on myeloid progenitors via the G-CSF receptor to accelerate neutrophil proliferation, differentiation, and release from the bone marrow.
Pegylation prolongs half-life and allows once-per-cycle dosing.
These agents reduce febrile neutropenia risk but can cause bone pain and, rarely, splenic complications.
Anemia:
Chemotherapy-induced anemia is addressed with erythropoiesis-stimulating agents such as:
- epoetin alfa
- darbepoetin alfa
These drugs activate erythropoietin receptors on erythroid progenitors to increase erythrocyte production.
However, their use is restricted due to risks of thromboembolism and potential tumor progression, and they are generally reserved for palliative settings with careful hemoglobin targets.
Thrombocytopenia:
- Oprelvekin: a recombinant human IL-11 drug used to prevent severe thrombocytopenia and reduce the need for platelet transfusions.
It acts as a thrombopoietic growth factor that stimulates the bone marrow to produce more megakaryocytes and platelets.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders